Annemieke Ter Telgte1, Kim Wiegertjes1, Benno Gesierich2, Brendon Sri Baskaran1, José P Marques3, Hugo J Kuijf4, David G Norris3, Anil M Tuladhar1, Marco Duering1,2,5, Frank-Erik de Leeuw1. 1. Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Center, Nijmegen, the Netherlands. 2. Institute for Stroke and Dementia Research (ISD), University Hospital LMU Munich, Munich, Germany. 3. Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the Netherlands. 4. Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands. 5. Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Abstract
Importance: Neuropathology studies show a high prevalence of cortical microinfarcts (CMIs) in aging individuals, especially in patients with cerebrovascular disease and dementia. However, most, are invisible on T1- and T2-weighted magnetic resonance imaging (MRI), raising the question of how to explain this mismatch. Studies on small acute infarcts, detected on diffusion-weighted imaging (DWI), suggest that infarcts are largest in their acute phase and reduce in size thereafter. Therefore, we hypothesized that a subset of the CMI that are invisible on MRI can be detected on MRI in their acute phase. However, to our knowledge, a serial imaging study investigating the temporal dynamics of acute CMI (A-CMI) is lacking. Objective: To determine the prevalence of chronic CMI (C-CMI) and the cumulative incidence and temporal dynamics of A-CMI in individuals with cerebral small vessel disease (SVD). Design, Setting, Participants and Exposures: The RUN DMC-Intense study is a single-center hospital-based prospective cohort study on SVD performed between March 2016 and November 2017 and comprising 10 monthly 3-T MRI scans, including high-resolution DWI, 3-dimensional T1, 3-dimensional fluid-attenuated inversion recovery, and T2. One hundred six individuals from the previous longitudinal RUN DMC study were recruited based on the presence of progression of white matter hyperintensities on MRI between 2006 and 2015 and exclusion of causes of cerebral ischemia other than SVD. Fifty-four individuals (50.9%) participated. The median total follow-up duration was 39.5 weeks (interquartile range, 37.8-40.3). Statistical data analysis was performed between May and October 2019. Main Outcomes and Measures: We determined the prevalence of C-CMI using the baseline T1, fluid-attenuated inversion recovery, and T2 scans. Monthly high-resolution DWI scans (n = 472) were screened to determine the cumulative incidence of A-CMI. The temporal dynamics of A-CMI were determined based on the MRI scans collected during the first follow-up visit after A-CMI onset and the last available follow-up visit. Results: The median age of the cohort at baseline MRI was 69 years (interquartile range, 66-74 years) and 34 participants (63%) were men. The prevalence of C-CMI was 35% (95% CI, 0.24-0.49). Monthly DWI detected 21 A-CMI in 7 of 54 participants, resulting in a cumulative incidence of 13% (95% CI, 0.06-0.24). All A-CMI disappeared on follow-up MRI. Conclusions and Relevance: Acute CMI never evolved into chronically MRI-detectable lesions. We suggest that these A-CMI underlie part of the submillimeter C-CMI encountered on neuropathological examination and thereby provide a source for the high CMI burden on neuropathology.
Importance: Neuropathology studies show a high prevalence of cortical microinfarcts (CMIs) in aging individuals, especially in patients with cerebrovascular disease and dementia. However, most, are invisible on T1- and T2-weighted magnetic resonance imaging (MRI), raising the question of how to explain this mismatch. Studies on small acute infarcts, detected on diffusion-weighted imaging (DWI), suggest that infarcts are largest in their acute phase and reduce in size thereafter. Therefore, we hypothesized that a subset of the CMI that are invisible on MRI can be detected on MRI in their acute phase. However, to our knowledge, a serial imaging study investigating the temporal dynamics of acute CMI (A-CMI) is lacking. Objective: To determine the prevalence of chronic CMI (C-CMI) and the cumulative incidence and temporal dynamics of A-CMI in individuals with cerebral small vessel disease (SVD). Design, Setting, Participants and Exposures: The RUN DMC-Intense study is a single-center hospital-based prospective cohort study on SVD performed between March 2016 and November 2017 and comprising 10 monthly 3-T MRI scans, including high-resolution DWI, 3-dimensional T1, 3-dimensional fluid-attenuated inversion recovery, and T2. One hundred six individuals from the previous longitudinal RUN DMC study were recruited based on the presence of progression of white matter hyperintensities on MRI between 2006 and 2015 and exclusion of causes of cerebral ischemia other than SVD. Fifty-four individuals (50.9%) participated. The median total follow-up duration was 39.5 weeks (interquartile range, 37.8-40.3). Statistical data analysis was performed between May and October 2019. Main Outcomes and Measures: We determined the prevalence of C-CMI using the baseline T1, fluid-attenuated inversion recovery, and T2 scans. Monthly high-resolution DWI scans (n = 472) were screened to determine the cumulative incidence of A-CMI. The temporal dynamics of A-CMI were determined based on the MRI scans collected during the first follow-up visit after A-CMI onset and the last available follow-up visit. Results: The median age of the cohort at baseline MRI was 69 years (interquartile range, 66-74 years) and 34 participants (63%) were men. The prevalence of C-CMI was 35% (95% CI, 0.24-0.49). Monthly DWI detected 21 A-CMI in 7 of 54 participants, resulting in a cumulative incidence of 13% (95% CI, 0.06-0.24). All A-CMI disappeared on follow-up MRI. Conclusions and Relevance: Acute CMI never evolved into chronically MRI-detectable lesions. We suggest that these A-CMI underlie part of the submillimeter C-CMI encountered on neuropathological examination and thereby provide a source for the high CMI burden on neuropathology.
Authors: Eitan Auriel; Brian L Edlow; Yael D Reijmer; Panagiotis Fotiadis; Sergi Ramirez-Martinez; Jun Ni; Anne K Reed; Anastasia Vashkevich; Kristin Schwab; Jonathan Rosand; Anand Viswanathan; Ona Wu; M Edip Gurol; Steven M Greenberg Journal: Neurology Date: 2014-06-11 Impact factor: 9.910
Authors: Marco Duering; Ruth Adam; Frank A Wollenweber; Anna Bayer-Karpinska; Ebru Baykara; Leidy Y Cubillos-Pinilla; Benno Gesierich; Miguel Á Araque Caballero; Sophia Stoecklein; Michael Ewers; Ofer Pasternak; Martin Dichgans Journal: J Cereb Blood Flow Metab Date: 2019-07-25 Impact factor: 6.200
Authors: Marco Duering; Sofia Finsterwalder; Ebru Baykara; Anil Man Tuladhar; Benno Gesierich; Marek J Konieczny; Rainer Malik; Nicolai Franzmeier; Michael Ewers; Eric Jouvent; Geert Jan Biessels; Reinhold Schmidt; Frank-Erik de Leeuw; Ofer Pasternak; Martin Dichgans Journal: Alzheimers Dement Date: 2018-02-16 Impact factor: 21.566
Authors: Inger Havsteen; Christian Ovesen; Lasse Willer; Janus Damm Nybing; Karen Ægidius; Jacob Marstrand; Per Meden; Sverre Rosenbaum; Marie Norsker Folke; Hanne Christensen; Anders Christensen Journal: BMJ Open Date: 2018-01-21 Impact factor: 2.692
Authors: Philipp M Summers; David A Hartmann; Edward S Hui; Xingju Nie; Rachael L Deardorff; Emilie T McKinnon; Joseph A Helpern; Jens H Jensen; Andy Y Shih Journal: J Cereb Blood Flow Metab Date: 2017-01-16 Impact factor: 6.200
Authors: Annemieke Ter Telgte; Kim Wiegertjes; Anil M Tuladhar; Marlies P Noz; José P Marques; Benno Gesierich; Mathias Huebner; Henk-Jan Mm Mutsaerts; Suzette E Elias-Smale; Marie-José Beelen; Stefan Ropele; Roy Pc Kessels; Niels P Riksen; Catharina Jm Klijn; David G Norris; Marco Duering; Frank-Erik de Leeuw Journal: Eur Stroke J Date: 2018-05-09
Authors: Kim Wiegertjes; Kwok-Shing Chan; Annemieke Ter Telgte; Benno Gesierich; David G Norris; Catharina Jm Klijn; Marco Duering; Anil M Tuladhar; José P Marques; Frank-Erik de Leeuw Journal: J Cereb Blood Flow Metab Date: 2021-08-20 Impact factor: 6.200